Latest News about Biotech
Recent news which mentions Biotech
SpringWorks Therapeutics Secures FDA Approval For Second Cancer Drug
February 12, 2025
From Benzinga
Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
February 12, 2025
From Benzinga
EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
February 12, 2025
From Benzinga
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
February 12, 2025
From Benzinga
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
February 11, 2025
From Benzinga
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
February 11, 2025
From Benzinga
Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo
February 11, 2025
From Benzinga
From Benzinga
From Benzinga
Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal
February 11, 2025
From Benzinga
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
February 11, 2025
From Benzinga
US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget
February 11, 2025
From Benzinga
What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday?
February 10, 2025
From Benzinga
Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'
February 10, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.